enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2026)
enVVeno Medical (NVNO) posted quarterly Cash from Investing Activities of $3.7 million for Q2 2026, up 29.94% year-over-year from $2.8 million in Q2 2025, and up 32.38% quarter-over-quarter from $2.8 million in Q1 2026.
enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2026) Analysis & Trends
enVVeno Medical's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $3.7 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 29.94% year-over-year to $3.7 million; the TTM figure through Jun 2026 stood at $14.3 million (up 347.76% YoY), while the FY2025 annual figure was $15.9 million, up 1087.72% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at $3.7 million, up from $2.8 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $7.0 million in Q2 2023, with the low at -$38.3 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is $3.2 million (2023), against an average of -$1.0 million.
- Peak annual rise in Cash from Investing Activities reached 8586.15% in 2022, while the deepest fall reached 30064.57% in 2022.
- enVVeno Medical's Cash from Investing Activities stood at $5.5 million in 2022, then slumped by 501.45% to -$22.1 million in 2023, then soared by 50.07% to -$11.1 million in 2024, then soared by 137.83% to $4.2 million in 2025, then declined by 12.31% to $3.7 million in 2026.
- Business Quant data shows NVNO's Cash from Investing Activities at $3.7 million in Q2 2026, $2.8 million in Q1 2026, and $4.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | enVVeno Medical | 7.12 Mn | 7.12 Mn | - | 3.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Mn |
| Jun 30, 2026 | 3.67 Mn |
| Mar 31, 2026 | 2.77 Mn |
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 4.18 Mn |
| Dec 31, 2025 | 4.18 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Sep 30, 2024 | 6.22 Mn |
| Sep 30, 2024 | 6.22 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |